Skip to content

Clinical trials

Phase 1 Memory Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Memory Disorders Phase: Phase 1 Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20062
20071
20103
20131
20141
20171
20182
20191
20231
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Not yet recruiting2
Unknown status2
Active, not recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Texas Southwestern Medical Center3
AstraZeneca2
National Institute on Aging (NIA)2
Prof. Dr. Dieter Willbold2
Ionis Pharmaceuticals, Inc.1
Kessler Foundation1
Life Extension Foundation Inc.1
Memorial Sloan Kettering Cancer Center1
Novartis Pharmaceuticals1
Posit Science Corporation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Memory Disorders18
Cognitive Dysfunction8
Alzheimer Disease6
Epilepsy3
Seizures3
Dementia2
Amnesia1
Astrocytoma1
Brain Diseases1
Brain Neoplasms1

Trials

Showing 76 to 18 of 18. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.